Print | PDF | Email Page

Life Sciences M&A

Jones Day’s M&A attorneys understand the business needs of pharmaceutical, medical device, and biotechnology companies. Working in collaboration with lawyers in the Firm’s Life Sciences Practice, our M&A lawyers apply their strategic skills and experience to develop novel ways to address the multidisciplinary challenges that arise in life sciences transactions. This combination of legal disciplines in a multi-jurisdictional approach maximizes value for our clients, from start-up, venture backed, or private equity owned companies, to the world’s largest pharmaceutical and medical device companies. 

Jones Day’s M&A lawyers structure and negotiate domestic and cross-border transactions involving products at all lifecycle stages - from discovery, development, and clinical testing to sale and promotion. These transactions routinely include public and private mergers, stock or asset acquisitions, spin-offs, joint ventures, strategic alliances, and other collaborative arrangements.
Featured Experience
Contact(s)
Jonn R. Beeson
Irvine
+1.949.553.7528
Bruce W. Raphael
Boston
+1.617.449.6899
Kevin B. Espinola
Irvine
+1.949.553.7509
Charles Gavoty
Paris
+33.1.56.59.39.39